NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM7098149 Query DataSets for GSM7098149
Status Public on Sep 30, 2024
Title PolyA_RNAseq_Patient_3_PB_pretreatment
Sample type SRA
 
Source name Peripheral blood
Organism Homo sapiens
Characteristics tissue: Peripheral blood
cell line: AML Patient 3
cell type: Haematopoietic
genotype: SF3B1-K666N
treatment: Pre-treatment
Treatment protocol K562 cells wild-type for SF3B1/SRSF2 or with knock-in of a single allele mutation in SF3B1-K700E, SF3B1-K666N, or SRSF2-P95H or NKM1 cells (which harbor a naturaly occurring U2AF1-Q157P mutation) were treated for 24 hours with DMSO vehicle or E7820 (1uM) treatment .
Growth protocol K562 cells wild-type for SF3B1/SRSF2 or with knock-in of a single allele mutation in SF3B1-K700E, SF3B1-K666N, or SRSF2-P95H or NKM1 cells (which harbor a naturaly occurring U2AF1-Q157P mutation) were cultured under standard in vitro culture conditions reccomended by vendors.
Extracted molecule polyA RNA
Extraction protocol RNA was extracted using the Qiagen RNeasy extraction kit, according to the manufacturer’s instructions.
A minimum of 500 ng of high-quality RNA (as determined by Agilent Bioanalyzer) per replicate was used as input for library preparation. Poly(A)-selected, strand-specific (dUTP method) Illumina libraries were prepared by the Integrated Genomics Operation (IGO) at Memorial Sloan Kettering Cancer Center (MSKCC) with a modified TruSeq protocol.
Libraries were sequenced on the Illumina HiSeq 2000 to obtain ∼100M 2x101 bp paired-end reads per sample.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2000
 
Description E7820_PolyA_RNAseq_raw_counts.csv
Data processing Prior to mapping, raw FASTQ files were trimmed using Trim_galore (v0.6.4) to remove residual Illumina adapter and/or low quality (Q<15) sequences. Trimmed sequencing reads were then aligned to the human Hg19 reference genome (GENCODE, GRCh37.p13) using STAR (v2.7.5).
Samtools (v1.9) was used to convert SAM files to BAM files, as well as sorting, and indexing.
Sorted BAM files were used for read counting across genomic features (exons) with featureCounts (part of the subread package; v1.5.0) (Liao et al., 2014) using the following parameters: -p -T 20 -O -F GTF -t exon.
The resultant counts file was used as input for differential gene expression analysis, which was performed using the edgeR (v3.32.1), DESeq2 (v1.30.1) (Love et al., 2014), and limma voom (v3.46.0) (Law et al., 2014) R packages.
Differential alternative splicing events were detected using Multivariate Analysis of Transcript Splicing (rMATS, v4.1.1) using the GENCODE (v19) GTF annotation for GRCh37.
Assembly: Hg19
Supplementary files format and content: CSV file of raw (non-normalized) gene expression counts produced by featureCounts.
 
Submission date Mar 14, 2023
Last update date Sep 30, 2024
Contact name Simon J Hogg
Organization name AbbVie
Department Oncology Discovery Research
Street address 1000 Gateway Boulevard
City South San Francisco
State/province California
ZIP/Postal code 94080
Country USA
 
Platform ID GPL11154
Series (1)
GSE227343 E7820, an Anti-Cancer Sulfonamide, Degrades RBM39 in Patients with Splicing Factor Mutant Myeloid Malignancies: A Phase II Clinical Trial
Relations
BioSample SAMN33759790
SRA SRX19676359

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap